GOLM1 and fibrosis: On average, patients with cirrhosis had higher median biomarker concentrations (GP73 152.49 ng/mL; LG2m 48.39 pg/mL) compared to patients with fibrosis GP73 72.12 ng/mL; LG2m 10.46 pg/mL; Fig. 1A, B).